Meleumycin

麦白霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMeleumycin
Drug Alias NameMidecamycin A1/Kitasamycin A6麦迪霉素A1/吉他霉素A6司奇乐
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionProtein biosynthesis inhibitors50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsSoft Tissue InfectionsRespiratory Tract Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Kitasamycin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAcute bacterial skin and skin structure infectionsSoft Tissue InfectionsRespiratory Tract Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A